| CPS Cito Pharma Services GmbH - Emselex 15 mg, Retardtabletten |
| 56871 | | 04 | | Emselex 15 mg | | Retardtabletten | | G04BD10 | | Darifenacin | | 22.06.2006 | | |
|
| Composition |
| darifenacinum 15 mg ut darifenacini hydrobromidum, calcii hydrogenophosphas dihydricus, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto. |
| Packungsbestandteile |
| Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Darifenacin | 15 mg |
| | BAG: Active Agent | Dose |
|---|
| Darifenacin | 15 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Calcium Hydrogen Phosphate Dihydrate | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | |
| |
|
| Teilbarkeit |
| | Nein | | | | Nein | | | | Nein | | | | -- | | | | Verlust der Retardwirkung | | | | | |
|
|
